Mar 182019
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, MA – Karuna Therapeutics, Inc., focused on targeting muscarinic cholinergic receptors for the treatment of neuropsychiatric disorders including psychosis in schizophrenia, psychosis in Alzheimer's disease, and pain, today announced the completion of a $68 million Series B financing round, including the issuance of $5 million in shares upon conversion of debt into equity.… => Read full post

Karuna Therapeutics adds Dr Heather Preston to Board along with raising $68m Series B financing led by ARCH Venture Partners

From:: Karuna Therapeutics adds Dr Heather Preston to Board along with raising $68m Series B financing led by ARCH Venture Partners

Sorry, the comment form is closed at this time.

%d bloggers like this: